Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 INDUSTRIAL INSIGHTS:
5 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATORS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL
6.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS
6.1.3 HIGH MAINTENANCE OF ASEPTIC CONDITIONS IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS
6.1.4 LOW OPERATING COST OF PHARMACEUTICAL ISOLATORS & GROWING DEMAND IN THE BIOPHARMACEUTICAL INDUSTRY
6.2 RESTRAINTS
6.2.1 STRINGENT GOVERNMENTAL REGULATIONS
6.2.2 HIGH COST OF INSTALLATION & LIMITED ADOPTION OF RABS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.2 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS
6.3.3 HIGH STERILITY ASSURANCE
6.4 CHALLENGES
6.4.1 LACK OF SKILLED EXPERTISE
6.4.2 ENGINEERING CHALLENGES FACED WHILE DESIGNING THE PHARMACEUTICAL ISOLATORS
7 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE
7.1 OVERVIEW
7.2 ASEPTIC ISOLATOR
7.3 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
7.4 CONTAINMENT ISOLATORS
7.5 BIO ISOLATORS
7.6 SAMPLING AND WEIGHING ISOLATORS
7.7 RADIOPHARMACEUTICAL ISOLATORS
7.8 PRODUCTION ISOLATORS
7.9 OTHERS
8 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE
8.1 OVERVIEW
8.2 OPEN SYSTEM
8.3 CLOSED SYSTEM
9 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE
9.1 OVERVIEW
9.2 POSITIVE PRESSURE
9.3 NEGATIVE PRESSURE
10 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION
10.1 OVERVIEW
10.2 FLOOR STANDING
10.3 MODULAR
10.4 MOBILE
10.5 COMPACT
10.6 TABLE TOP
10.7 PORTABLE
10.8 OTHERS
11 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 STERILITY TESTING
11.3 MANUFACTURING
11.4 SAMPLING/WEIGHING/DISTRIBUTION
11.5 MEDICAL DEVICE MANUFACTURING
12 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 THIRD PARTY DISTRIBUTORS
13 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER
13.1 OVERVIEW
13.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
13.2.1 STERILE FILTERING
13.2.2 AMPULE FILLING
13.2.3 SYRINGE FILLING
13.2.4 SAMPLING
13.2.5 SAMPLE TESTING
13.2.6 STERILITY TESTING
13.2.7 PACKAGING
13.2.8 OTHERS
13.3 CONTRACT RESEARCH ORGANIZATION
13.3.1 STERILE FILTERING
13.3.2 AMPULE FILLING
13.3.3 SYRINGE FILLING
13.3.4 SAMPLING
13.3.5 SAMPLE TESTING
13.3.6 STERILITY TESTING
13.3.7 PACKAGING
13.3.8 OTHERS
13.4 ACADEMIC AND RESEARCH INSTITUTES
13.4.1 STERILE FILTERING
13.4.2 AMPULE FILLING
13.4.3 SYRINGE FILLING
13.4.4 SAMPLING
13.4.5 SAMPLE TESTING
13.4.6 STERILITY TESTING
13.4.7 PACKAGING
13.4.8 OTHERS
13.5 HOSPITALS
13.5.1 STERILE FILTERING
13.5.2 AMPULE FILLING
13.5.3 SYRINGE FILLING
13.5.4 SAMPLING
13.5.5 SAMPLE TESTING
13.5.6 STERILITY TESTING
13.5.7 PACKAGING
13.5.8 OTHERS
13.6 DIAGNOSTIC LABORATORIES
13.6.1 STERILE FILTERING
13.6.2 AMPULE FILLING
13.6.3 SYRINGE FILLING
13.6.4 SAMPLING
13.6.5 SAMPLE TESTING
13.6.6 STERILITY TESTING
13.6.7 PACKAGING
13.6.8 OTHERS
13.7 OTHERS
14 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY REGION
14.1 MIDDLE EAST & AFRICA
14.1.1 SOUTH AFRICA
14.1.2 SAUDI ARABIA
14.1.3 U.A.E
14.1.4 EGYPT
14.1.5 ISRAEL
14.1.6 REST OF MIDDLE EAST AND AFRICA
15 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATORS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 GETINGE AB
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 AZBIL CORPORATION
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 CHIYODA CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 HOSOKAWA MICRON LTD
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 BIOQUELL, AN ECOLAB SOLUTION (A SUBSIDIARY OF ECOLAB)
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 CHAMUNDA PHARMA MACHNIERY
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 COMECER S.P.A. (A SUBSIDIARY OF ATS AUTOMATION TOOLS) (2021)
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 ENVAIR TECHNOLOGY
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 ESCO MICRO PTE. LTD
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 FEDEGARI AUTOCLAVI S.P.A
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 GERMFREE LABORATORIES, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 GELMAN SINGAPORE
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 HECT TECHNOLOGIE GMBH (2021)
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 ISO TECH DESIGN
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 ITECO SRL
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 JACOMEX
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 LAF TECHNOLOGIES
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 MBRAUN.(2021)
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 NUAIRE (A SUBSIDIARY OF GENUIT GROUP PLC)
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
17.21 STERILINE (2021)
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 SCHEMATIC ENGINEERING INDUSTRY
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENTS
17.23 SKAN AG
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 TEMA SINERGIE S.P.A
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 OPERATING COSTS FOR ASEPTIC PRODUCTION UNDER RABS OR ISOLATOR
TABLE 2 APPLICATION OF GUI-0104 TO API MANUFACTURING
TABLE 3 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA ASEPTIC ISOLATOR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA CONTAINMENT ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA BIO ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA SAMPLING AND WEIGHING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA RADIOPHARMACEUTICAL ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA PRODUCTION ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA OPEN SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA CLOSED SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA POSITIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA NEGATIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA FLOOR STANDING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA MODULAR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA MOBILE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA COMPACT IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA TABLE TOP IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA PORTABLE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA STERILITY TESTING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA SAMPLING/WEIGHING/DISTRIBUTION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA MEDICAL DEVICE MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA DIRECT TENDER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA RETAIL SALES INPHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA DIAGNOSTIC LABARATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA DIAGNOSTICS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 60 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 61 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 62 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 63 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 64 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 65 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 66 SOUTH AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 67 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 68 SOUTH AFRICA ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 69 SOUTH AFRICA HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 SOUTH AFRICA DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 71 SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 72 SAUDI ARABIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 73 SAUDI ARABIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 74 SAUDI ARABIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 75 SAUDI ARABIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 76 SAUDI ARABIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 77 SAUDI ARABIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 78 SAUDI ARABIA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 79 SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 80 SAUDI ARABIA ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 81 SAUDI ARABIA HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 82 SAUDI ARABIA DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 83 SAUDI ARABIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 84 UAE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 85 UAE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 86 UAE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 87 UAE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 88 UAE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 89 UAE PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 90 UAE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 91 UAE CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 92 UAE ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 93 UAE HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 94 UAE DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 95 UAE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 96 EGYPT PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 97 EGYPT PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 98 EGYPT PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 99 EGYPT PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 100 EGYPT PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 101 EGYPT PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 102 EGYPT PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 103 EGYPT CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 104 EGYPT ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 105 EGYPT HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 106 EGYPT DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 107 EGYPT PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 108 ISRAEL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 109 ISRAEL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 110 ISRAEL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 111 ISRAEL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 112 ISRAEL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 113 ISRAEL PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 114 ISRAEL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 115 ISRAEL CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 116 ISRAEL ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 117 ISRAEL HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 118 ISRAEL DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 119 ISRAEL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 120 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION
FIGURE 11 INCREASING USE OF PHARMACEUTICAL ISOLATORS IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 ASEPTIC ISOLATORS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET
FIGURE 14 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE, 2021
FIGURE 15 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 17 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2021
FIGURE 19 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2022-2029 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, CAGR (2022-2029)
FIGURE 21 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE, 2021
FIGURE 23 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE, 2022-2029 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE, CAGR (2022-2029)
FIGURE 25 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2021
FIGURE 27 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2022-2029 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, CAGR (2022-2029)
FIGURE 29 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2021
FIGURE 31 MIDDLE EAST & AFRICAPHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 33 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 34 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 35 MIDDLE EAST & AFRICAPHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 36 MIDDLE EAST & AFRICAPHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 37 MIDDLE EAST & AFRICAPHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET : BY END USER, 2021
FIGURE 39 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET : BY END USER, 2022-2029 (USD MILLION)
FIGURE 40 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET : BY END USER, CAGR (2022-2029)
FIGURE 41 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET : BY END USER, LIFELINE CURVE
FIGURE 42 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2021)
FIGURE 43 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2021)
FIGURE 44 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET: TYPE (2022-2029)
FIGURE 47 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2021 (%)
